Health Care / Hospitals News and Press Releases

Health Care / Hospitals

Releases published in the last 30 days.

Page 1 of 3

AdvaMed Earns WTOP News Regional Top Workplaces 2026 Award, Culture Excellence Awards: 6/22/2026 8:27:24 AM; AdvaMed, the largest trade association representing medtech innovators, announced it is a WTOP News Top Workplaces 2026 award winner in the Washington, D.C., region and received five Culture Excellence awards.
Senate panel passes NO FAKES Act; AMA urges Congressional approval: 6/22/2026 8:16:18 AM; Statement attributable to: John Whyte, MD, MPH CEO, American Medical Association “The NO FAKES Act is the real deal—an important step toward ensuring that innovation serves people, not those seeking to deceive them.
Rising Silicosis Cases Linked to Engineered Stone Highlight the Need for Better Worker Protections: 6/19/2026 12:40:43 PM; Engineered stone, commonly marketed as quartz countertops, has become one of the most popular materials used in modern kitchens and bathrooms. While valued for its durability and sleek appearance, the material is also drawing growing attention from occupational health experts due to serious health risks for workers who fabricate and install it.
Save the Children Welcomes House Introduction of Bipartisan Child Care Modernization Act, Calls on Additional Lawmakers to Co-Sponsor: 6/19/2026 9:26:16 AM; Save the Children and its advocacy arm, Save the Children Action Network (SCAN), welcome the introduction of the Child Care Modernization Act in the House of Representatives and urge additional lawmakers to back the bipartisan proposal aimed at expanding access to affordable, quality childcare for hardworking families across the country.
“Beyond Feet on Fire,” Best-Selling Book Free for One More Day (Ending Soon) (Until 6/19/26): 6/19/2026 6:00:00 AM; Best Seller Publishing announces the release of Dr. Paul Fisher’s new book, “Beyond Feet on Fire: How To Reverse Neuropathy Without Drugs and Surgery.” The book is currently free and available for download on Amazon for one more day.
Vali Health Raises $6M to Build Responsible AI Infrastructure for Home Care Agencies: 6/17/2026 9:35:05 AM; Vali Health, a startup building responsible AI infrastructure for the home care industry, today emerged from stealth with $6 million in funding from Bonfire Ventures, Supernode, Comma Capital, along with Jacquelyn Kung, an industry veteran who built two of the largest software platforms for home care.
“Beyond Feet on Fire,” Best-Selling Book Offered for Free (Ending Soon) (Until 6/19/26): 6/17/2026 6:00:00 AM; Best Seller Publishing announces the release of Dr. Paul Fisher’s new book, “Beyond Feet on Fire: How To Reverse Neuropathy Without Drugs and Surgery.” It will be available in the Amazon store for free for two more days.
A tiny ingestible sensor can measure temperature from inside the body: 6/16/2026 8:00:21 AM; In a hospital or at home, temperatures are usually taken using an oral or forehead thermometer, but these do not always accurately reflect the core body temperature.
ATA Action Bringing Top Federal Policy Priorities to Capitol Hill to Support Permanent Access to Virtual Care and Digital Health Tools: 6/16/2026 7:29:55 AM; ATA Action, the affiliated policy and legislative advocacy arm of the American Telemedicine Association, met with 35 Congressional offices, House and Senate leadership offices, and key committee leaders during its 4 th annual Hill Day on June 10, to advance federal policies that support permanent access to telehealth and digital health tools and encourage innovation in …
Alicia Baca Rush’s “The Good Kind of Cancer” To Be Displayed at a Book Festival at Printers Row, Chicago: 6/15/2026 8:58:30 PM; Alicia Baca Rush’s book, “The Good Kind of Cancer: Turning Pain Into Purpose — One Day At A Time — A Health Memòria,” will be showcased by the self-publishing and book marketing company ReadersMagnet at an upcoming book festival at Printers Row in Chicago.
Heartseed Announces First Patient Dosed in a Phase I/II EMERALD Study with HS-005 – a Cell Therapy Administered via Catheter, Designed to Restore Heart Function in People with Severe Heart Failure: 6/15/2026 12:16:05 PM; Nikon CeLL innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation (Nikon), manufactures iPSC-derived purified cardiomyocyte spheroids of HS-005, under contract to Heartseed Inc.(Heartseed).
New tool for measuring synbiotic synergy potential could shape the next wave of food and drink innovation supporting gut health: 6/15/2026 11:00:42 AM; Tate & Lyle PLC (Tate & Lyle), a global leader in ingredient solutions for healthier food and beverages, welcomes the publication of a new peer-reviewed study from world-leading APC Microbiome Ireland at University College Cork, supported in part by research grants from Tate & Lyle and Research Ireland.
CONV2X Announces Smart Technology Transformation in Healthcare & Life Sciences Summit in New York City: 6/15/2026 10:56:45 AM; CONV2X Smart Technology Transformation in Healthcare & Life Sciences, announced its annual two-day executive summit taking place October 29–30, 2026 at the Historic GE Building, ILR Conference Center, 570 Lexington Avenue, New York, NY.
Elsevier launches Ebola Information Center with free clinical and research resources to support response to outbreak: 6/15/2026 10:54:14 AM; Following the World Health Organization’s declaration of an Ebola outbreak caused by Bundibugyo virus in the Democratic Republic of Congo and Uganda as a Public Health Emergency of International Concern (PHEIC), Elsevier, a global leader in scientific information and analytics, has launched its Ebola Information Center to provide healthcare professionals, researchers, …
Ultomiris granted Priority Review in the US as treatment for adults with immunoglobulin A nephropathy: 6/15/2026 10:48:37 AM; Based on I CAN Phase III trial results from prespecified interim analysis in which Ultomiris demonstrated 43.4% reduction in proteinuria vs placebo at 34 weeks If approved, Ultomiris would be the first C5 complement inhibitor available for this rare kidney disease Alexion, AstraZeneca Rare Disease’s supplemental Biologics License Application (sBLA) for …
Caring for non-communicable diseases during pregnancy, expert convening: 6/15/2026 10:36:28 AM; The World Health Organization (WHO) is developing new recommendations to improve care for pregnant and postpartum women living with noncommunicable diseases (NCDs).
“Beyond Feet on Fire” is Free to Download for Only Five Days (Until 6/19/26): 6/15/2026 6:00:00 AM; Best Seller Publishing announces the release of Dr. Paul Fisher’s new book, “Beyond Feet on Fire: How To Reverse Neuropathy Without Drugs and Surgery.” It will be available in the Amazon store for free for only five days.
Bombardier Defense Expands Collaboration with Aero-Dienst/ADAC with a Second Challenger 650 Aircraft for Medevac: 6/12/2026 10:48:35 AM; • Bombardier Defense signs deal with German-based operator Aero-Dienst GmbH, a wholly owned subsidiary of ADAC SE, for a second Bombardier Challenger 650 aircraft that will be added to its medevac fleet • The Challenger 650 aircraft supports critical missions worldwide with proven reliability, long-range performance and cabin flexibility • Additional aircraft …
Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients: 6/12/2026 10:38:47 AM; • Expanded U.S. availability paired with new patient lifestyle quiz encourages informed decision-making ahead of cataract surgery. • Cataracts are one of the leading causes of vision impairment.1 Nearly 20% of Americans aged 40+ live with cataracts that make everyday tasks more challenging, yet only 5% have had cataract surgery.2 • Over half a million eyes worldwide …
Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy: 6/10/2026 6:17:01 PM; Sanofi today announced that the riliprubart MOBILIZE phase 3 study (clinical study identifier: NCT06290128) in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) refractory to standard-of-care treatment will be stopped.